1. Home
  2. STAA vs USPH Comparison

STAA vs USPH Comparison

Compare STAA & USPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STAA
  • USPH
  • Stock Information
  • Founded
  • STAA 1982
  • USPH 1990
  • Country
  • STAA United States
  • USPH United States
  • Employees
  • STAA N/A
  • USPH N/A
  • Industry
  • STAA Ophthalmic Goods
  • USPH Medical/Nursing Services
  • Sector
  • STAA Health Care
  • USPH Health Care
  • Exchange
  • STAA Nasdaq
  • USPH Nasdaq
  • Market Cap
  • STAA 1.3B
  • USPH 1.4B
  • IPO Year
  • STAA N/A
  • USPH 1992
  • Fundamental
  • Price
  • STAA $26.68
  • USPH $98.08
  • Analyst Decision
  • STAA Buy
  • USPH Buy
  • Analyst Count
  • STAA 7
  • USPH 3
  • Target Price
  • STAA $43.33
  • USPH $105.00
  • AVG Volume (30 Days)
  • STAA 638.2K
  • USPH 129.8K
  • Earning Date
  • STAA 10-30-2024
  • USPH 11-05-2024
  • Dividend Yield
  • STAA N/A
  • USPH 1.79%
  • EPS Growth
  • STAA 9.97
  • USPH N/A
  • EPS
  • STAA 0.44
  • USPH 0.94
  • Revenue
  • STAA $341,224,000.00
  • USPH $639,062,000.00
  • Revenue This Year
  • STAA $8.45
  • USPH $12.67
  • Revenue Next Year
  • STAA $12.35
  • USPH $9.05
  • P/E Ratio
  • STAA $61.31
  • USPH $105.08
  • Revenue Growth
  • STAA 10.01
  • USPH 9.20
  • 52 Week Low
  • STAA $25.88
  • USPH $76.18
  • 52 Week High
  • STAA $52.68
  • USPH $113.63
  • Technical
  • Relative Strength Index (RSI)
  • STAA 35.57
  • USPH 69.59
  • Support Level
  • STAA $25.88
  • USPH $87.71
  • Resistance Level
  • STAA $32.00
  • USPH $97.41
  • Average True Range (ATR)
  • STAA 1.22
  • USPH 3.48
  • MACD
  • STAA -0.18
  • USPH 0.45
  • Stochastic Oscillator
  • STAA 13.07
  • USPH 97.27

About STAA STAAR Surgical Company

Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of sales are generated from the ophthalmic surgical product segment.

About USPH U.S. Physical Therapy Inc.

US Physical Therapy Inc through its subsidiaries operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. The principal sources of payment for the clinics' services are managed care programs, commercial health insurance, Medicare/Medicaid, workers' compensation insurance, and proceeds from personal injury cases. Its operating segment includes Physical therapy operations and Industrial injury prevention services. The company generates maximum revenue from the Physical therapy operations segment.

Share on Social Networks: